Canine leukocyte cell adhesion molecules (LeuCAMs): Characterization of the CD11/CD18 family

D. M. Danilenko, Peter F Moore, P. V. Rossitto

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Abstract: The canine LeuCAM (CD11/CD18) family is characterized using a panel of newly developed anti‐canine LeuCAM monoclonal antibodies (mAb) as well as a cross‐reactive anti‐human CD11b mAb. The new anti‐canine LeuCAM mAb were developed by immunizing mice with purified canine CD11/CD18 antigen derived from an anti‐canine CD18 affinity column. Six mAb with reactivity to the canine LeuCAM family were cloned and characterized. These 6 included a new anti‐canine CD18 mAb, 2 anti‐canine CD11a mAb, 2 anti‐canine CD11c mAb, and a mAb which recognizes a novel canine CD11/CD18‐related macrophage antigen, designated LeuCAMmac, which is described in a separate report. The cell and tissue distribution of canine LeuCAMs was found to be similar to that reported in other species with a few notable exceptions. One prominent exception was the finding that canine CD11c, in contrast to human CD11c, was much more widely distributed on dendritic cells than it was on tissue macrophages. The molecular organization of the canine LeuCAM family was also found to be similar to that reported in other species, with the possible exception of the canine CD11b α chain, which may exist as several different species. It is anticipated that these anticanine LeuCAM mAb will prove useful in immunophenotypic studies of canine hemolymphatic system neoplasia. 1992 Blackwell Munksgaard

Original languageEnglish (US)
Pages (from-to)13-21
Number of pages9
JournalTissue Antigens
Volume40
Issue number1
DOIs
StatePublished - 1992

Fingerprint

Cell Adhesion Molecules
Canidae
Monoclonal Antibodies
CD11 Antigens
CD18 Antigens
Macrophages
Tissue Distribution
Dendritic Cells

Keywords

  • adhesion molecules
  • canine
  • CD11/CD18
  • integrins
  • leukocyte antigens

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Genetics

Cite this

Canine leukocyte cell adhesion molecules (LeuCAMs) : Characterization of the CD11/CD18 family. / Danilenko, D. M.; Moore, Peter F; Rossitto, P. V.

In: Tissue Antigens, Vol. 40, No. 1, 1992, p. 13-21.

Research output: Contribution to journalArticle

@article{debbe549b8c449e5ae3afccd3d32880d,
title = "Canine leukocyte cell adhesion molecules (LeuCAMs): Characterization of the CD11/CD18 family",
abstract = "Abstract: The canine LeuCAM (CD11/CD18) family is characterized using a panel of newly developed anti‐canine LeuCAM monoclonal antibodies (mAb) as well as a cross‐reactive anti‐human CD11b mAb. The new anti‐canine LeuCAM mAb were developed by immunizing mice with purified canine CD11/CD18 antigen derived from an anti‐canine CD18 affinity column. Six mAb with reactivity to the canine LeuCAM family were cloned and characterized. These 6 included a new anti‐canine CD18 mAb, 2 anti‐canine CD11a mAb, 2 anti‐canine CD11c mAb, and a mAb which recognizes a novel canine CD11/CD18‐related macrophage antigen, designated LeuCAMmac, which is described in a separate report. The cell and tissue distribution of canine LeuCAMs was found to be similar to that reported in other species with a few notable exceptions. One prominent exception was the finding that canine CD11c, in contrast to human CD11c, was much more widely distributed on dendritic cells than it was on tissue macrophages. The molecular organization of the canine LeuCAM family was also found to be similar to that reported in other species, with the possible exception of the canine CD11b α chain, which may exist as several different species. It is anticipated that these anticanine LeuCAM mAb will prove useful in immunophenotypic studies of canine hemolymphatic system neoplasia. 1992 Blackwell Munksgaard",
keywords = "adhesion molecules, canine, CD11/CD18, integrins, leukocyte antigens",
author = "Danilenko, {D. M.} and Moore, {Peter F} and Rossitto, {P. V.}",
year = "1992",
doi = "10.1111/j.1399-0039.1992.tb01952.x",
language = "English (US)",
volume = "40",
pages = "13--21",
journal = "HLA",
issn = "2059-2302",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Canine leukocyte cell adhesion molecules (LeuCAMs)

T2 - Characterization of the CD11/CD18 family

AU - Danilenko, D. M.

AU - Moore, Peter F

AU - Rossitto, P. V.

PY - 1992

Y1 - 1992

N2 - Abstract: The canine LeuCAM (CD11/CD18) family is characterized using a panel of newly developed anti‐canine LeuCAM monoclonal antibodies (mAb) as well as a cross‐reactive anti‐human CD11b mAb. The new anti‐canine LeuCAM mAb were developed by immunizing mice with purified canine CD11/CD18 antigen derived from an anti‐canine CD18 affinity column. Six mAb with reactivity to the canine LeuCAM family were cloned and characterized. These 6 included a new anti‐canine CD18 mAb, 2 anti‐canine CD11a mAb, 2 anti‐canine CD11c mAb, and a mAb which recognizes a novel canine CD11/CD18‐related macrophage antigen, designated LeuCAMmac, which is described in a separate report. The cell and tissue distribution of canine LeuCAMs was found to be similar to that reported in other species with a few notable exceptions. One prominent exception was the finding that canine CD11c, in contrast to human CD11c, was much more widely distributed on dendritic cells than it was on tissue macrophages. The molecular organization of the canine LeuCAM family was also found to be similar to that reported in other species, with the possible exception of the canine CD11b α chain, which may exist as several different species. It is anticipated that these anticanine LeuCAM mAb will prove useful in immunophenotypic studies of canine hemolymphatic system neoplasia. 1992 Blackwell Munksgaard

AB - Abstract: The canine LeuCAM (CD11/CD18) family is characterized using a panel of newly developed anti‐canine LeuCAM monoclonal antibodies (mAb) as well as a cross‐reactive anti‐human CD11b mAb. The new anti‐canine LeuCAM mAb were developed by immunizing mice with purified canine CD11/CD18 antigen derived from an anti‐canine CD18 affinity column. Six mAb with reactivity to the canine LeuCAM family were cloned and characterized. These 6 included a new anti‐canine CD18 mAb, 2 anti‐canine CD11a mAb, 2 anti‐canine CD11c mAb, and a mAb which recognizes a novel canine CD11/CD18‐related macrophage antigen, designated LeuCAMmac, which is described in a separate report. The cell and tissue distribution of canine LeuCAMs was found to be similar to that reported in other species with a few notable exceptions. One prominent exception was the finding that canine CD11c, in contrast to human CD11c, was much more widely distributed on dendritic cells than it was on tissue macrophages. The molecular organization of the canine LeuCAM family was also found to be similar to that reported in other species, with the possible exception of the canine CD11b α chain, which may exist as several different species. It is anticipated that these anticanine LeuCAM mAb will prove useful in immunophenotypic studies of canine hemolymphatic system neoplasia. 1992 Blackwell Munksgaard

KW - adhesion molecules

KW - canine

KW - CD11/CD18

KW - integrins

KW - leukocyte antigens

UR - http://www.scopus.com/inward/record.url?scp=0026766957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026766957&partnerID=8YFLogxK

U2 - 10.1111/j.1399-0039.1992.tb01952.x

DO - 10.1111/j.1399-0039.1992.tb01952.x

M3 - Article

C2 - 1359668

AN - SCOPUS:0026766957

VL - 40

SP - 13

EP - 21

JO - HLA

JF - HLA

SN - 2059-2302

IS - 1

ER -